Physician profile
Devon Duplain
NPI 1508373929
$618.82
in general payments reported to CMS, 2019-2025
9 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $136 · 2023: $136 · 2024: $97.77 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $167.97 | 2021-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $154.10 | 2022-2025 | Orthovisc, Monovisc, Peak |
| Bioventus LLC | $71.68 | 2021-2025 | Durolane, Durolane |
| Avanos Medical | $66.12 | 2022-2025 | Genvisc 850 Sodium Hyaluronate, Trivisc Sodium Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $58.31 | 2023-2025 | Zilretta, Exparel, Iovera |
| Pacira Therapeutics, INC. | $50.27 | 2021 | |
| Zimmer Biomet Holdings, INC. | $18.84 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.97 | 2023 | |
| Solventum Corporation | $15.56 | 2025 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Duplain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.